Eli Lilly and Company is a pharmaceutical enterprise founded in 1876 and headquartered in Indianapolis, Indiana, operating at a substantial scale with approximately 48,000 employees worldwide. The company discovers, develops, and manufactures medicines across multiple therapeutic areas, including diabetes care and obesity treatments, alongside other specialised fields.
The organisation's operations span the full pharmaceutical value chain: from drug discovery and development through clinical therapeutics to medicine manufacturing and production. This breadth requires expertise in quality assurance, regulatory compliance, and patient engagement - disciplines that inform both scientific rigour and practical implementation at scale.
Eli Lilly's approach centres on addressing genuine patient needs through high-quality medicines. The company emphasises listening to patients, understanding their circumstances, and building growth strategies that benefit people and society alongside the business itself. With nearly 150 years of operational history, the organisation has developed institutional capabilities in translating scientific innovation into therapies that reach patients globally.
